Cyclacel Pharmaceuticals's total assets for Q1 2025 were $3.73K, a decrease of -99.91% from the previous quarter. CYCC total liabilities were $672.00 for the fiscal quarter, a -99.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.